JPM vs SAMG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
SAMG presents a precarious financial profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect. The current price of $13.73 trades at a significant premium to both the Graham Number ($9.02) and the Intrinsic Value ($3.92). Most concerning is the unsustainable dividend payout ratio of 146.43%, which suggests the dividend is being funded by capital or debt rather than earnings. This, combined with stagnant revenue growth and a consistent track record of earnings misses, indicates a high risk of a price correction.
Compare Another Pair
Related Comparisons
JPM vs SAMG: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Silvercrest Asset Management Group Inc. (SAMG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.